9-130450341-C-T

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2

The NM_054012.4(ASS1):​c.-5-1883C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00251 in 987,336 control chromosomes in the GnomAD database, including 38 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.010 ( 26 hom., cov: 33)
Exomes 𝑓: 0.0011 ( 12 hom. )

Consequence

ASS1
NM_054012.4 intron

Scores

2
Splicing: ADA: 0.00001812
2

Clinical Significance

Benign criteria provided, single submitter B:2

Conservation

PhyloP100: 0.296

Publications

4 publications found
Variant links:
Genes affected
ASS1 (HGNC:758): (argininosuccinate synthase 1) The protein encoded by this gene catalyzes the penultimate step of the arginine biosynthetic pathway. There are approximately 10 to 14 copies of this gene including the pseudogenes scattered across the human genome, among which the one located on chromosome 9 appears to be the only functional gene for argininosuccinate synthetase. Mutations in the chromosome 9 copy of this gene cause citrullinemia. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Aug 2012]
ASS1 Gene-Disease associations (from GenCC):
  • citrullinemia type I
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Myriad Women’s Health, G2P
  • acute neonatal citrullinemia type I
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • adult-onset citrullinemia type I
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 9-130450341-C-T is Benign according to our data. Variant chr9-130450341-C-T is described in ClinVar as [Benign]. Clinvar id is 381450.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0101 (1532/152318) while in subpopulation AFR AF = 0.0346 (1437/41562). AF 95% confidence interval is 0.0331. There are 26 homozygotes in GnomAd4. There are 730 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 26 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ASS1NM_054012.4 linkc.-5-1883C>T intron_variant Intron 1 of 14 ENST00000352480.10 NP_446464.1 P00966Q5T6L4
ASS1NM_000050.4 linkc.-6+8C>T splice_region_variant, intron_variant Intron 2 of 15 NP_000041.2 P00966Q5T6L4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ASS1ENST00000352480.10 linkc.-5-1883C>T intron_variant Intron 1 of 14 1 NM_054012.4 ENSP00000253004.6 P00966
ASS1ENST00000372393.7 linkc.-6+8C>T splice_region_variant, intron_variant Intron 2 of 15 5 ENSP00000361469.2 P00966
ASS1ENST00000372394.5 linkc.-447-1261C>T intron_variant Intron 1 of 15 2 ENSP00000361471.1 P00966
ASS1ENST00000422569.5 linkc.-5-1883C>T intron_variant Intron 1 of 7 5 ENSP00000394212.1 Q5T6L6

Frequencies

GnomAD3 genomes
AF:
0.0100
AC:
1529
AN:
152200
Hom.:
26
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0346
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00432
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000265
Gnomad OTH
AF:
0.00478
GnomAD4 exome
AF:
0.00114
AC:
951
AN:
835018
Hom.:
12
Cov.:
29
AF XY:
0.00107
AC XY:
413
AN XY:
385746
show subpopulations
African (AFR)
AF:
0.0368
AC:
583
AN:
15832
American (AMR)
AF:
0.00301
AC:
3
AN:
998
Ashkenazi Jewish (ASJ)
AF:
0.000194
AC:
1
AN:
5160
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3642
South Asian (SAS)
AF:
0.00
AC:
0
AN:
16498
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
872
Middle Eastern (MID)
AF:
0.00703
AC:
16
AN:
2276
European-Non Finnish (NFE)
AF:
0.000356
AC:
271
AN:
762256
Other (OTH)
AF:
0.00280
AC:
77
AN:
27484
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
41
82
124
165
206
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0101
AC:
1532
AN:
152318
Hom.:
26
Cov.:
33
AF XY:
0.00980
AC XY:
730
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.0346
AC:
1437
AN:
41562
American (AMR)
AF:
0.00431
AC:
66
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000265
AC:
18
AN:
68032
Other (OTH)
AF:
0.00473
AC:
10
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
71
142
212
283
354
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0103
Hom.:
2
Bravo
AF:
0.0114
Asia WGS
AF:
0.00231
AC:
8
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
Dec 10, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Citrullinemia type I Benign:1
Apr 09, 2018
Natera, Inc.
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
7.7
DANN
Benign
0.44
PhyloP100
0.30
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000018
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12004384; hg19: chr9-133325728; API